Comparable to the findings of UroA, the researchers reported significant reduction of the cell proliferation marker Ki-67 in the UroB-treated mice model, while also reducing the size of the tumour growth compared to the vehicle-treated group. This evidence concerns the gene MKI67 and neoplasm.